It's the million-dollar question: how should insurers respond to an emerging class of gene therapeutics that promise to cure or ease debilitating genetic disorders, rare diseases and cancers but can cost upwards of $1 million per treatment. Learn highlights from...

Read More

For insurers, the current puzzle is how to develop cost-effective products for mental health disorders with sufficient flexibility to cover a range of risks and maintain positive customer experiences, says RGA's Dipali Jawalkar, Executive D...

Read More

Curious about RGA’s Global Genetics Survey results? 

Read More

Brain fog ... blurred vision ... loss of taste ... these are just a few of the lingering, and sometimes debilitating, symptoms reported by COVID-19 long-haulers. Read More

Aligning Critical Illness definitions with clinical diagnoses is not an easy task, and the speed of medical advances can lead to difficulties applying CI definitions at claims stage. RGA's Marilda Kotze and Anne Casey explore some of the common challenges that this c...

Read More

Medicine never stands still; so neither can underwriting. For accurate, best-in-class risk calculation, the industry needs precise, flexible, and convenient solutions.

RGA has harnessed its global research and data science capabilities and partnered with clients ... Read More

Curious about RGA's data science insights?  Contact us to le...

Read More

The novel coronavirus has forced many of us to confront our own vulnerability to loss and to think more seriously about planning for our family’s protection, according to RGA's Dr. Dave Rengachary. He calls on the industry to consider how to make insurance products more... Read More

The global effort to develop mRNA-based vaccines for COVID-19 has greatly advanced mRNA technology and increased the speed of mRNA vaccine development, and it is likely that new mRNA vaccines for other diseases will soon emerge. Read More

Challenges have a way of driving change. RGA's Naohiro Iwamoto looks back at the pandemic year of 2020 and surveys the many ways COVID-19 has accelerated change throughout the insurance industry and beyond.

Read More

Could anxiety and uncertainty fuelled by an ongoing pandemic lead to a mental health crisis? RGA's Enrique Ruiz, Managing Director of Spain and Portugal, explores this question in

Read More

The global burden of gestational diabetes mellitus (GDM) is on the rise alongside increases in obesity and changing lifestyles. In ReFlections, RGA's Dr. Reema Nathwani Jani explores the history, complications, management, and long-term outcomes of GDM on ma...

Read More

Underwriting pulmonary and thyroid nodules has always been a distinct challenge. In a two-part article for ReFlections, RGA's Sandeepan Basu seeks to simplify the underwriting challenges associated with both types of nodules by identifying factors to ... Read More

Rapid advances in medical science’s understanding of the human genome have led to the recent development of novel gene-based therapeutic strategies. In ReFlections, RGA's Dr.Dan Zimmerman defines gene and cell therapies and provides insights into these rapid...

Read More

Insurance-linked wellness reward programs can too often fail to pay for themselves, and data from wearable devices is not yet widely or confidently used in underwriting risk assessment. RGA's Raajeev Bhayana explores the relationships between wearable data and health...

Read More

In this issue, explore topics from demystifying pulmonary and thyroid nodules to current trends in gestational diabetes and gene therapy. 
Read More

Long before the current pandemic, vaccines have proven to be historical game-changers in the prevention of infectious diseases. RGA sat down with Senior Vice President and Head of Global Medical Dr. Daniel Zimmerman and Global Medical Researcher Hilary Henly to discuss ... Read More

After a torrid compound annual growth rate of 43% since 2013, the Middle East health insurance market is experiencing growing pains, including challenges to sustainability and profitability. A new survey from RGA identifies causes and solutions.

Read More

Read More

Curious about RGA's medical insights?  Contact us to learn m...

Read More